Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
LGG Probiotic in Pregnancy Complications
NCT02693041Completed
- Sponsor
- Sahlgrenska University Hospital
- Start
- Jun 2012
- Primary completion
- Sep 2021
- Modality
- Live Biotherapeutic Products
- Countries
- 1
01
Overview
Randomised, double-blind trial of Lactobacillus rhamnosus GG in preeclampsia and preterm birth (6 arms), sponsored by Sahlgrenska University Hospital. Primary endpoint: Inflammatory modulation of Lactobacillus Rhamnosus at week 35. Started Jun 2012; status: completed.
02
Drugs
Lactobacillus rhamnosus GG
03
Conditions
preeclampsiapreterm birth
Beyond the preview
Go deeper on NCT02693041.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02693041.